Supplemental material
Open access
766
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Risk factors for recurrence in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in Japan: a systematic literature review and meta-analysis
Naoki Miyazakia Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japanhttps://orcid.org/0000-0001-7753-5191
, Toshiki Iwasakia Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japanhttps://orcid.org/0000-0001-8377-1406
, Hitomi Sakaib Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japanhttps://orcid.org/0000-0001-8396-9121
, Rurina Watanukic Department of Breast Surgery, National Cancer Center Hospital East, Kashiwa, Japanhttps://orcid.org/0000-0002-7462-4137
, Yoshinori Tanizawad Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japanhttps://orcid.org/0000-0002-5014-2483
, Zhihong Caid Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japanhttps://orcid.org/0000-0002-3431-197X
, Tsutomu Kawaguchid Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japanhttps://orcid.org/0000-0001-6182-9005
, Junji Tsurutanib Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japanhttps://orcid.org/0000-0002-6260-6943
& Kengo Nagashimaa Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0003-4529-9045
show allhttps://orcid.org/0000-0003-4529-9045
Pages 827-837
|
Received 19 Oct 2023, Accepted 14 Mar 2024, Published online: 10 Apr 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.